Considerations for Patient Diversity in Cardiovascular Clinical Trials
AI Webinar Explorer now available for enhanced on-demand viewing
About this webinar
Patient diversity in clinical research populations has become a strategic focus of stakeholders throughout the industry and by regulatory authorities throughout the world. There are many common challenges in the recruitment and retention of diverse populations for participation in clinical trials. But, with the right strategy, an ongoing commitment to ensuring representation and a collaborative effort between the CRO, the sponsor and investigative sites, representative diversity in trial populations can be achieved. The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.
Join the featured speakers as they discuss challenges and considerations surrounding the recruitment and retention of diverse patient populations to ensure appropriate representation in clinical research.
Who should attend
- Clinical Affairs
- Clinical Research
- Clinical Pharmacology
- Clinical Outsourcing
- Project Management
- Regulatory Affairs
- Medical Affairs
What you will learn
- The importance of achieving diversity, equity and inclusion in clinical trials
- Common challenges associated with recruiting and retaining historically underrepresented populations in clinical trials; as well as strategies to overcome them
- How to identify strategies to increase interest, accessibility and trial participation for patients in underrepresented populations
Featured Speakers
Sara Sampaio, MD, CCRP
Dr. Sampaio has over eight years’ experience in patient recruitment management at the site level. She has managed a global team of strategic partners, support staff and vendors for multimillion-dollar global marketing, patient recruitment and patient retention campaigns. She received her medical degree from Federal University of Bahia in Salvador, Brazil.
Hansie M. Mathelier, MD, FACC
Dr. Mathelier is a cardiologist in Philadelphia, Pennsylvania and is affiliated with multiple hospitals in the area, including Hospitals of the University of Pennsylvania-Penn Presbyterian and Penn Presbyterian Medical Center. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for 17 years.
Satya Shreenivas, MD
Dr. Shreenivas is an interventional cardiologist bringing over ten years of experience in clinical practice, academia and clinical research. He serves as Director of the University of Cincinnati HLVI Center for Structural and Adult Congenital Heart Disease and Section Head of the UC Catheterization Lab.
Partner for this event
Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
Related webinars
More from Medpace.
Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight
Beyond the Protocol: Advancing Patient- and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
3 Key Trends Transforming the Future of Rare Disease Clinical Development
Advancing Obesity Clinical Development: Emerging Strategies for Next‑Gen Trials
Advancing Atherosclerotic Cardiovascular Disease Trials Through Innovative Imaging Endpoints
Shaping the Future of Rheumatology Trials: Operational Strategies, Industry Trends and Breakthroughs in Cell and Gene Therapies
Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials
Innovative Approaches in Metabolic Dysfunction-Associated Steatohepatitis Clinical Research
Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach
Women’s Health Awareness Month: The Evolving Women’s Health Clinical Development Landscape
A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials